About
Contact & Profiles
A5007047436
Research Areas
- Advancements in Transdermal Drug Delivery
- Proteoglycans and glycosaminoglycans research
- Pancreatic and Hepatic Oncology Research
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Advanced Drug Delivery Systems
- Cancer Research and Treatments
- Cancer Cells and Metastasis
University of Nebraska Medical Center
2024
Quaid-i-Azam University
2020
10.1016/j.jddst.2020.102281
article
EN
Journal of Drug Delivery Science and Technology
2020-12-09
Background/Objectives: Pancreatic cancer is the third leading cause of death related to cancer. The only possible cure presently complete surgical resection; however, this limited by difficulty in clearly defining tumor margins. Enhancement visualization pancreatic ductal adenocarcinoma (PDAC) margins using near-infrared dye-conjugated tumor-specific antibodies was pioneered anti-CEA, anti-CA19.9, and anti-MUC5AC orthotopic mouse models Recently, an antibody Mucin 4 (MUC4) conjugated a...
10.3390/jcm13206211
article
EN
Journal of Clinical Medicine
2024-10-18
Coming Soon ...